Hem › Wilms tumör › Missouri
Kliniska studier för Wilms tumör i Missouri
4 studier för Wilms tumör söker deltagare vid platser i Missouri.
Städer i Missouri
Officiell studietext (engelska)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Washington University School of Medicine, St Louis
RekryterarFas 2
Ålder 12 till 39 · Alla kön · Uppdaterad 29 sep. 2026 · NCT04616560A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- University of Missouri Children's Hospital, Columbia
- Children's Mercy Hospitals and Clinics, Kansas City
- Cardinal Glennon Children's Medical Center, St Louis
- och 2 fler
RekryterarFas 2
Upp till ålder 30 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04322318Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Washington University School of Medicine, St Louis
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Washington University, St Louis
RekryterarFas 2
12 Months · Alla kön · Uppdaterad 6 maj 2026 · NCT05985161Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.